Communicating end of trial results to participants

A suggested process for communicating end of trial results to people who took part in a typical antimalarial drug trial

 

 

Publication Version
v1.0
Publication Code
AD13
Procedure Author
WWARN

It is considered good practice to thank and communicate trial results to the participants who took part in a trial. This document therefore describes a process for undertaking this task in a typical antimalarial drug trial after the trial is finished.